Literature DB >> 12094226

Smallpox: anything to declare?

Geoffrey L Smith1, Grant McFadden.   

Abstract

Smallpox was eradicated in 1977, but it remains a concern owing to the potential use of the causative agent variola virus in bioterrorism. This article provides an overview of the World Health Organization's spectacular success in achieving the eradication of smallpox. It discusses how variola virus could potentially re-emerge and how prepared we are to counter such a re-emergence. Finally, the potential threat from other orthopoxviruses that exist naturally or that have been genetically engineered is considered. In the words of Rep. Christopher Shay, 'Better to be scared by the improbable possibility than to be unprepared for the catastrophic reality'.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094226     DOI: 10.1038/nri845

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  47 in total

1.  Antiviral immunity following smallpox virus infection: a case-control study.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Motomi Mori; Caroline W Koudelka; Mark K Slifka
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Smallpox: an ancient disease enters the modern era of virogenomics.

Authors:  Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-12       Impact factor: 11.205

3.  Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Authors:  Yuan Zhao; Yan Fei Adams; Michael Croft
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

4.  Genome of horsepox virus.

Authors:  E R Tulman; G Delhon; C L Afonso; Z Lu; L Zsak; N T Sandybaev; U Z Kerembekova; V L Zaitsev; G F Kutish; D L Rock
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.

Authors:  Marcos De la Peña; Otto J P Kyrieleis; Stephen Cusack
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

6.  Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Eric L Simpson; Nichole E Carlson; Mark K Slifka
Journal:  Vaccine       Date:  2007-11-29       Impact factor: 3.641

7.  Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.

Authors:  Shuji Hatakeyama; Kyoji Moriya; Masayuki Saijo; Yuji Morisawa; Ichiro Kurane; Kazuhiko Koike; Satoshi Kimura; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

8.  Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system.

Authors:  James J McSharry; Mark R Deziel; Kris Zager; Qingmei Weng; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

Review 9.  Killing a killer: what next for smallpox?

Authors:  Grant McFadden
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

10.  Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Authors:  Claire M Midgley; Mike M Putz; Jonathan N Weber; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.